Vimarsana
Biggest News Aggregation in the World

Page 9 - Systemic Lupus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Lupus Today - Breaking & Trending Today

BioSenic provides financial update and financial calendar 2023 - Vimarsana News

BioSenic provides financial update and financial calendar 2023

BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases and cellular repair, provides today a financial update and publishes its financial calendar for the year 2023. Financial Update As a result of cost management efforts made and payments ...

BioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO) - Vimarsana News

BioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO)

INSIDE INFORMATION Combination of ATO with copper salts will allow BioSenic to work towards reducing the dosage of ATO in future trials overall and maintain efficacy Mont-Saint-Guibert,... | March 30, 2023

Best CBD Oil for Lupus 2023 - The Most Trustworthy Brands - Vimarsana News

Best CBD Oil for Lupus 2023 - The Most Trustworthy Brands

For some patients, CBD oil products have proven valuable in treating inflammation and lupus. Find out the best CBD oils for lupus in 2023.

BioSenic announces initiation of coverage by Portzamparc and Gilbert Dupont - Vimarsana News

BioSenic announces initiation of coverage by Portzamparc and Gilbert Dupont

Mont-Saint-Guibert, Belgium, February 14, 2023, 5:45 pm CET – BioSenic , the clinical stage company specializing in serious autoimmune / inflammatory diseases and cell repair, today... | February 14, 2023

BioSenic appoints Yves Sagot as Independent Director - Vimarsana News

BioSenic appoints Yves Sagot as Independent Director

REGULATED INFORMATION Mont-Saint-Guibert, Belgium, January 27, 2023, 7am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company...